{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:34:24Z","timestamp":1771914864661,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T00:00:00Z","timestamp":1455926400000},"content-version":"vor","delay-in-days":780,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ihj.2013.12.017","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T20:00:17Z","timestamp":1389124817000},"page":"64-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preventing rheumatic fever: M-protein based vaccine"],"prefix":"10.1016","volume":"66","author":[{"given":"Rajendra","family":"Tandon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2013.12.017_bib1","series-title":"Rheumatic Fever","first-page":"69","article-title":"Lessons learned from the resurgence of rheumatic fever in the United States","author":"Veasy","year":"1999"},{"key":"10.1016\/j.ihj.2013.12.017_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198702193160801","article-title":"Resurgence of acute rheumatic fever in the intermountain area of the United states","volume":"316","author":"Veasy","year":"1987","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ihj.2013.12.017_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of streptococcus hemolyticus-1, demonstration of a type specific substance in extracts of streptococcus hemolyticus","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med"},{"key":"10.1016\/j.ihj.2013.12.017_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type specific M-antigens of group A, streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"key":"10.1016\/j.ihj.2013.12.017_bib5","series-title":"Rheumatic Fever","first-page":"113","article-title":"Streptococcal M protein: structure, function and immunology","author":"Fischetti","year":"1999"},{"key":"10.1016\/j.ihj.2013.12.017_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M-protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ihj.2013.12.017_bib7","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1073\/pnas.76.8.3765","article-title":"Amino acid sequence and physicochemical similarities between streptococcal M-protein and mammalian tropomyosin","volume":"76","author":"Hosain","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ihj.2013.12.017_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.151.3.695","article-title":"Tropomyosin \u2013 like seven residue periodicity in three immunologically distinct streptococcal M-proteins and its implications for the anti phagocytic property of the molecule","volume":"151","author":"Manjula","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.ihj.2013.12.017_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","article-title":"Pathogenesis of group-A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ihj.2013.12.017_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.2578225","article-title":"Myosin, a link between streptococci and heart","volume":"227","author":"Krisher","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ihj.2013.12.017_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.54.9.740","article-title":"Rheumatic fever; auto-antibodies against a variety of cardiac, nuclear and streptococcal antigens","volume":"54","author":"Eichbaum","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ihj.2013.12.017_bib12","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.138.8.2488","article-title":"Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3 induced myocarditis","volume":"138","author":"Neu","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.ihj.2013.12.017_bib13","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26 valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.ihj.2013.12.017_bib14","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M-protein based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ihj.2013.12.017_bib15","first-page":"276","article-title":"Group A streptococcus; challenges in multivalent M-protein aminoterminal based vaccine development in India and elsewhere","volume":"2","author":"Sharma","year":"2012","journal-title":"J Prev Cardiol"},{"key":"10.1016\/j.ihj.2013.12.017_bib16","first-page":"49","article-title":"Heterogeneity of community based pediatric GAS isolates from India: challenges to the multivalent vaccine approach","author":"Sharma","year":"2006"},{"key":"10.1016\/j.ihj.2013.12.017_bib17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0140-6736(01)06415-7","article-title":"Dynamic epidemiology of group A streptococcus serotypes associated with pharyngitis","volume":"358","author":"Kaplan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2013.12.017_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/infdis\/159.1.101","article-title":"Group-A streptococcal serotypes isolated from patients and siblings during the resurgence of rheumatic fever in the United States in the mid 1980's","volume":"159","author":"Kaplan","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ihj.2013.12.017_bib19","series-title":"Rheumatic Fever","first-page":"41","article-title":"Epidemiology of streptocoecal pharyngitis, rheumatic fever and rheumatic heart disease","author":"Krishna Kumar","year":"1999"},{"key":"10.1016\/j.ihj.2013.12.017_bib20","series-title":"Abstract 05.6 XV Lancefield International Symposium on Streptococci and Streptococcal Disease","article-title":"Highly virulent group-A streptococci that appear not to express M-protein","author":"Bennett-Wood","year":"2002"},{"key":"10.1016\/j.ihj.2013.12.017_bib21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00504.x","article-title":"Is the nephritogenic antigen in post streptococcal glomerulonephritis pyrogenic exotoxin B (SPE-B) or GAPDH?","volume":"68","author":"Batsford","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ihj.2013.12.017_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/0974-2069.99621","article-title":"Rheumatic fever pathogenesis: approach in research needs change","volume":"5","author":"Tandon","year":"2012","journal-title":"Ann Pediatr Cardiol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483213003957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483213003957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:01:00Z","timestamp":1688911260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483213003957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0019483213003957"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2013.12.017","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing rheumatic fever: M-protein based vaccine","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2013.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Cardiological Society of India. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}